CLINICAL_TRIALS
trial_result
· 2017-10-06
Clinical Trial Update: Study of OLT1177 Gel to Treat Moderate to Severe OA Knee Pain [Phase 2]
Summary
Phase 2 trial (NCT02104050) of OLT1177 Gel for moderate to severe knee osteoarthritis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Olatec Therapeutics LLC | Conditions: Osteoarthritis, Pain | Phase 2 | Status: COMPLETED